研究业绩（2004-byoyaku.pha.nihon.doc

病院薬学ユニット　研究紀要（2006.4～2007.3） 学会誌等発表要旨 31. 学会誌 The realities and Medical Expense of Hospitalization that Originates in Outpatient Medicine Treatment Masayoshi KOINUMA , Takahisa YAMANASHI , KAMEI Miwako , Makoto SHIRAGAMI College of Pharmacy,Nihon University ［YAKUGAKU ZASSI.126(5)373-378(2006)］ Problems associated with outpatient pharmacotherapy may require hospitalization. However, such hospitalization may be prevented if pharmacists pharmaceutical care (PC) is given. We investigated the reasons for hospitalization in medical institutions and medical expenses were calculated. Inpatient diagnoses, treatment, etc. in the previous year in the past were examined, and cases of hospitalization due to drug therapy were extracted. Next, the possibility of preventing hospitalization with PC practice was examined. Among 1552 cases, outpatient pharmacotherapy was the reason for hospitalization in 27 cases. Noncompliance was the underlying cause in about 40% of hospitalizations. It was thought that in 22 cases hospitalization could have been prevented by pharmacists PC. The average hospitalization medical expense was \295,805 per patient. It is necessary to perform regular consultation recommendations, interventions with the family, home care, etc. for proactive PC. First-line chemotherapy weekly paclitaxel and carboplatin compared to monthly paclitaxel and carboplatin by Pharmacoeconomic comparisons in advance non-small cell lung cancer Hitoshi NARIKAWA1, Masayoshi KOINUMA1, Miwako KAMEI1, Naohiko　CHOUNABAYASHI2, Tadao INOUE3, Makoto SHIRAGAMI1 1.College of Pharmacy,Nihon University 2.St Lukes International hospital Department of Respiratory Medicine 3.St Lukes International hospital　Department of Pharmacy ［医薬品情報学,8(1),5-34(2006) ］ 【Objective】 In this study, a statistical and pharmaeconomic comparison was made to evaluate initial chemotherapies (Carboplatin and Monthly Paclitaxel andCarboplatin and Weekly Paclitaxel) of advanced non-small cell l